Hyperkalemia Recruiting Phase 3 Trials for Valsartan (DB00177)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05056727A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTreatment